| UniProt ID | RNF13_HUMAN | |
|---|---|---|
| UniProt AC | O43567 | |
| Protein Name | E3 ubiquitin-protein ligase RNF13 | |
| Gene Name | RNF13 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 381 | |
| Subcellular Localization |
Endoplasmic reticulum membrane. Golgi apparatus membrane. Late endosome membrane Single-pass membrane protein. Lysosome membrane. Nucleus inner membrane. Under certain conditions, relocalizes to recycling endosomes and to the inner nuclear membrane. |
|
| Protein Description | E3 ubiquitin-protein ligase that may play a role in controlling cell proliferation.. | |
| Protein Sequence | MLLSIGMLMLSATQVYTILTVQLFAFLNLLPVEADILAYNFENASQTFDDLPARFGYRLPAEGLKGFLINSKPENACEPIVPPPVKDNSSGTFIVLIRRLDCNFDIKVLNAQRAGYKAAIVHNVDSDDLISMGSNDIEVLKKIDIPSVFIGESSANSLKDEFTYEKGGHLILVPEFSLPLEYYLIPFLIIVGICLILIVIFMITKFVQDRHRARRNRLRKDQLKKLPVHKFKKGDEYDVCAICLDEYEDGDKLRILPCSHAYHCKCVDPWLTKTKKTCPVCKQKVVPSQGDSDSDTDSSQEENEVTEHTPLLRPLASVSAQSFGALSESRSHQNMTESSDYEEDDNEDTDSSDAENEINEHDVVVQLQPNGERDYNIANTV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 42 | Ubiquitination | DILAYNFENASQTFD CEEEECCCCHHCCCC | 48.53 | 22817900 | |
| 44 | Ubiquitination | LAYNFENASQTFDDL EEECCCCHHCCCCCC | 8.87 | 22817900 | |
| 45 | Ubiquitination | AYNFENASQTFDDLP EECCCCHHCCCCCCC | 41.14 | 21963094 | |
| 85 | Ubiquitination | EPIVPPPVKDNSSGT CCCCCCCCCCCCCCE | 17.52 | 25015289 | |
| 87 | Ubiquitination | IVPPPVKDNSSGTFI CCCCCCCCCCCCEEE | 61.55 | 25015289 | |
| 88 | N-linked_Glycosylation | VPPPVKDNSSGTFIV CCCCCCCCCCCEEEE | 32.15 | 18794910 | |
| 93 | Ubiquitination | KDNSSGTFIVLIRRL CCCCCCEEEEEEEEE | 4.08 | 33845483 | |
| 94 | Ubiquitination | DNSSGTFIVLIRRLD CCCCCEEEEEEEEEC | 2.18 | 33845483 | |
| 99 | Ubiquitination | TFIVLIRRLDCNFDI EEEEEEEEECCCCEE | 28.08 | 33845483 | |
| 101 | Ubiquitination | IVLIRRLDCNFDIKV EEEEEEECCCCEEEE | 24.41 | 22817900 | |
| 102 | Ubiquitination | VLIRRLDCNFDIKVL EEEEEECCCCEEEEC | 6.91 | 21963094 | |
| 105 | Ubiquitination | RRLDCNFDIKVLNAQ EEECCCCEEEECCHH | 26.30 | 33845483 | |
| 106 | Ubiquitination | RLDCNFDIKVLNAQR EECCCCEEEECCHHH | 2.66 | 33845483 | |
| 107 | Ubiquitination | LDCNFDIKVLNAQRA ECCCCEEEECCHHHC | 42.38 | - | |
| 111 | Ubiquitination | FDIKVLNAQRAGYKA CEEEECCHHHCCCEE | 8.97 | 33845483 | |
| 113 | Ubiquitination | IKVLNAQRAGYKAAI EEECCHHHCCCEEEE | 27.80 | 22817900 | |
| 113 | Ubiquitination | IKVLNAQRAGYKAAI EEECCHHHCCCEEEE | 27.80 | - | |
| 114 | Ubiquitination | KVLNAQRAGYKAAIV EECCHHHCCCEEEEE | 17.37 | - | |
| 114 | Ubiquitination | KVLNAQRAGYKAAIV EECCHHHCCCEEEEE | 17.37 | 21963094 | |
| 121 | Ubiquitination | AGYKAAIVHNVDSDD CCCEEEEEECCCHHH | 2.00 | 33845483 | |
| 133 | Ubiquitination | SDDLISMGSNDIEVL HHHHCCCCCCCHHHH | 19.26 | 33845483 | |
| 134 | Ubiquitination | DDLISMGSNDIEVLK HHHCCCCCCCHHHHH | 23.76 | 33845483 | |
| 142 | Ubiquitination | NDIEVLKKIDIPSVF CCHHHHHHCCCCEEE | 41.26 | 33845483 | |
| 144 | Ubiquitination | IEVLKKIDIPSVFIG HHHHHHCCCCEEECC | 56.47 | 25015289 | |
| 146 | Ubiquitination | VLKKIDIPSVFIGES HHHHCCCCEEECCCC | 22.23 | 33845483 | |
| 151 | Ubiquitination | DIPSVFIGESSANSL CCCEEECCCCCCCCC | 19.78 | 33845483 | |
| 154 | Ubiquitination | SVFIGESSANSLKDE EEECCCCCCCCCCCE | 27.45 | 33845483 | |
| 154 | Ubiquitination | SVFIGESSANSLKDE EEECCCCCCCCCCCE | 27.45 | - | |
| 156 | Ubiquitination | FIGESSANSLKDEFT ECCCCCCCCCCCEEE | 50.23 | 25015289 | |
| 157 | Ubiquitination | IGESSANSLKDEFTY CCCCCCCCCCCEEEE | 36.19 | - | |
| 163 | Ubiquitination | NSLKDEFTYEKGGHL CCCCCEEEEEECCEE | 28.82 | 33845483 | |
| 224 | Ubiquitination | RLRKDQLKKLPVHKF HCCHHHHHCCCCCCC | 46.78 | 33845483 | |
| 225 | Ubiquitination | LRKDQLKKLPVHKFK CCHHHHHCCCCCCCC | 67.62 | 33845483 | |
| 230 | Ubiquitination | LKKLPVHKFKKGDEY HHCCCCCCCCCCCCC | 60.14 | 33845483 | |
| 232 | Ubiquitination | KLPVHKFKKGDEYDV CCCCCCCCCCCCCCE | 61.73 | 22817900 | |
| 233 | Ubiquitination | LPVHKFKKGDEYDVC CCCCCCCCCCCCCEE | 74.79 | 21963094 | |
| 247 | Phosphorylation | CAICLDEYEDGDKLR EEEEEEECCCCCEEE | 20.98 | - | |
| 252 | Ubiquitination | DEYEDGDKLRILPCS EECCCCCEEEEEECC | 45.23 | 33845483 | |
| 265 | Ubiquitination | CSHAYHCKCVDPWLT CCCEEECEECCHHHC | 24.79 | 33845483 | |
| 273 | Ubiquitination | CVDPWLTKTKKTCPV ECCHHHCCCCCCCCC | 57.06 | 33845483 | |
| 275 | Ubiquitination | DPWLTKTKKTCPVCK CHHHCCCCCCCCCCC | 47.87 | 25015289 | |
| 276 | Ubiquitination | PWLTKTKKTCPVCKQ HHHCCCCCCCCCCCC | 61.67 | - | |
| 282 | Ubiquitination | KKTCPVCKQKVVPSQ CCCCCCCCCEECCCC | 54.08 | 33845483 | |
| 309 | Phosphorylation | ENEVTEHTPLLRPLA HHCHHCCCCCHHHHH | 14.92 | 24275569 | |
| 317 | Phosphorylation | PLLRPLASVSAQSFG CCHHHHHHHCHHHHC | 25.04 | 27732954 | |
| 319 | Phosphorylation | LRPLASVSAQSFGAL HHHHHHHCHHHHCCC | 20.35 | 26657352 | |
| 322 | Phosphorylation | LASVSAQSFGALSES HHHHCHHHHCCCCCC | 25.93 | 26657352 | |
| 327 | Phosphorylation | AQSFGALSESRSHQN HHHHCCCCCCCCCCC | 32.75 | 27732954 | |
| 329 | Phosphorylation | SFGALSESRSHQNMT HHCCCCCCCCCCCCC | 35.39 | 27732954 | |
| 380 | Phosphorylation | RDYNIANTV------ CCCCCCCCC------ | 20.69 | 23663014 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RNF13_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RNF13_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| LAMP2_HUMAN | LAMP2 | physical | 19292867 | |
| CD63_HUMAN | CD63 | physical | 19292867 | |
| PGRC1_HUMAN | PGRMC1 | physical | 19292867 | |
| LMNB1_HUMAN | LMNB1 | physical | 20230530 | |
| SNAPN_HUMAN | SNAPIN | physical | 22890573 | |
| UB2D1_HUMAN | UBE2D1 | physical | 22890573 | |
| ERN1_HUMAN | ERN1 | physical | 23378536 | |
| AP3S2_HUMAN | AP3S2 | physical | 26186194 | |
| AP3D1_HUMAN | AP3D1 | physical | 26186194 | |
| HDGR3_HUMAN | HDGFRP3 | physical | 26186194 | |
| AP3S1_HUMAN | AP3S1 | physical | 26186194 | |
| TYK2_HUMAN | TYK2 | physical | 26186194 | |
| COT2_HUMAN | NR2F2 | physical | 26186194 | |
| COT1_HUMAN | NR2F1 | physical | 26186194 | |
| CD63_HUMAN | CD63 | physical | 26186194 | |
| TSN3_HUMAN | TSPAN3 | physical | 26186194 | |
| CLCN7_HUMAN | CLCN7 | physical | 26186194 | |
| AP3S2_HUMAN | AP3S2 | physical | 28514442 | |
| AP3S1_HUMAN | AP3S1 | physical | 28514442 | |
| TYK2_HUMAN | TYK2 | physical | 28514442 | |
| AP3D1_HUMAN | AP3D1 | physical | 28514442 | |
| TSN3_HUMAN | TSPAN3 | physical | 28514442 | |
| RN167_HUMAN | RNF167 | physical | 28514442 | |
| COT2_HUMAN | NR2F2 | physical | 28514442 | |
| DCX_HUMAN | DCX | physical | 28514442 | |
| AP1S2_HUMAN | AP1S2 | physical | 28514442 | |
| CLCN7_HUMAN | CLCN7 | physical | 28514442 | |
| HDGR3_HUMAN | HDGFRP3 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "RNF13: a novel RING-type ubiquitin ligase over-expressed inpancreatic cancer."; Zhang Q., Meng Y., Zhang L., Chen J., Zhu D.; Cell Res. 19:348-357(2009). Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,AUTOUBIQUITINATION, GLYCOSYLATION AT ASN-88, AND MUTAGENESIS OFASN-43; ASN-88; CYS-258; HIS-260 AND TRP-270. | |